Viewing Study NCT06971406


Ignite Creation Date: 2025-12-26 @ 2:41 PM
Ignite Modification Date: 2025-12-26 @ 2:41 PM
Study NCT ID: NCT06971406
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-05-14
First Post: 2025-04-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: High-Dose Firmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed in the Treatment of EGFR-Mutated Non-Small Cell Lung Cancer With Leptomeningeal Metastasis
Sponsor: Qiming Wang
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module